NDC 10956-180

Reeses TABtussin

Guaifenesin

Reeses TABtussin is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Reese Pharmaceutical Co. The primary component is Guaifenesin.

Product ID10956-180_7803da73-0ae2-4745-84e5-7cf98374c0f5
NDC10956-180
Product TypeHuman Otc Drug
Proprietary NameReeses TABtussin
Generic NameGuaifenesin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-09-26
Marketing CategoryOTC MONOGRAPH FINAL /
Application Numberpart341
Labeler NameReese Pharmaceutical Co
Substance NameGUAIFENESIN
Active Ingredient Strength400 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 10956-180-24

2 BLISTER PACK in 1 CARTON (10956-180-24) > 12 TABLET in 1 BLISTER PACK
Marketing Start Date2021-03-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Reeses TABtussin" or generic name "Guaifenesin"

NDCBrand NameGeneric Name
0363-0288childrens chest congestionGuaifenesin
0113-0325Good Sense Mucus ERGuaifenesin
0113-2023good sense mucus erguaifenesin
0113-3650Good Sense Mucus ERGuaifenesin
0113-0061good sense tussinGuaifenesin
0121-0744GUAIFENESINGUAIFENESIN
0121-1488GUAIFENESINGUAIFENESIN
0121-1744GUAIFENESINGUAIFENESIN
0121-2232GUAIFENESINGUAIFENESIN
0363-0028GuaifenesinGuaifenesin
0363-0033GuaifenesinGuaifenesin
0363-0071MucusGuaifenesin
0363-0074MucusGuaifenesin
0363-0532Mucus ReliefGuaifenesin
0363-0325mucus relief erGuaifenesin
0031-9303Robitussin Direct Chest Congestionguaifenesin
0031-8724Robitussin Mucus Plus Chest CongestionGuaifenesin
0113-2061tussinGuaifenesin
0363-0310wal tussinGuaifenesin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.